TrialClinical rheumatology2013

Golimumab reduces disease activity of rheumatoid arthritis for 1 year and strongly inhibits radiographic progression in Japanese patients: partial but detailed results of the GO-FORTH and GO-MONO studies.

Masatoshi Hayashi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.